retatrutide clinical trial obesity Up to 28.7% weight loss sounds wild… but let's talk about what the data actually says. 👇 This carousel breaks down the Phase 3 TRIUMPH-4 trial—without the hype, without the fear-mongering retatrutide phase 2 trial obesity

Mounjaro (tirzepatide) Mounjaro ( tirzepatide ) is another medication with a dual-action mechanism , targeting GLP-1 and GIP receptors but, unlike retatrutide, it doesnt target glucagon receptors

When your sleep is optimized, your body has the foundation it needs to support all other health goals more effectively

Wilsons disease is the paradigmatic example: an inherited defect in the ATP7B copper-transport protein that impairs the bodys ability to remove excess copper, causing toxic copper accumulation in the liver, brain, eyes, and other organs

However, gastrointestinal events were notably common, with up to 66% of participants reporting nausea, vomiting, or diarrhea